NRX Pharmaceuticals Stock Price

-4.74 (-19.12%)
Upgrade to Real-Time
Regular Market


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
NRX Pharmaceuticals Inc NRXP NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-4.74 -19.12% 20.035 12:27:03
Open Price Low Price High Price Close Price Prev Close
21.95 19.01 23.77 24.77
Bid Price Ask Price Spread News
19.90 20.04 0.14 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
51,625 6,842,619 $ 20.73 $ 141,863,319 - 8.39 - 26.24
Last Trade Time Type Quantity Stock Price Currency
12:27:04 3 $ 19.90 USD


Draw Mode:

NRX Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 959.97M 47.91M 47.82M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 32.05M 0.20%

more financials information »

NRX Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NRXP Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week12.5026.249.7617.4936,349,5867.5460.28%
1 Month14.1126.248.3917.319,815,2585.9341.99%
3 Months23.0126.248.3917.314,551,770-2.98-12.93%
6 Months23.0126.248.3917.314,551,770-2.98-12.93%
1 Year23.0126.248.3917.314,551,770-2.98-12.93%
3 Years23.0126.248.3917.314,551,770-2.98-12.93%
5 Years23.0126.248.3917.314,551,770-2.98-12.93%

NRX Pharmaceuticals Description

NRX Pharmaceuticals Inc is a clinical-stage, small molecule pharmaceutical company which develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. It is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

Your Recent History
NRX Pharma..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.